- Home
- MRNA vs HST Comparison
MRNA vs HST Comparison
Compare MRNA & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- HST
- Stock Information
- Founded
- MRNA 2010
- HST 1927
- Country
- MRNA United States
- HST United States
- Employees
- MRNA N/A
- HST N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- HST Real Estate Investment Trusts
- Sector
- MRNA Health Care
- HST Real Estate
- Exchange
- MRNA Nasdaq
- HST Nasdaq
- Market Cap
- MRNA 10.6B
- HST 11.9B
- IPO Year
- MRNA 2018
- HST N/A
- Fundamental
- Price
- MRNA $24.25
- HST $14.77
- Analyst Decision
- MRNA Hold
- HST Buy
- Analyst Count
- MRNA 20
- HST 15
- Target Price
- MRNA $51.94
- HST $18.90
- AVG Volume (30 Days)
- MRNA 8.3M
- HST 8.3M
- Earning Date
- MRNA 05-01-2025
- HST 04-30-2025
- Dividend Yield
- MRNA N/A
- HST 6.09%
- EPS Growth
- MRNA N/A
- HST N/A
- EPS
- MRNA N/A
- HST 0.96
- Revenue
- MRNA $3,177,000,000.00
- HST $5,816,000,000.00
- Revenue This Year
- MRNA N/A
- HST $4.20
- Revenue Next Year
- MRNA $22.14
- HST $2.82
- P/E Ratio
- MRNA N/A
- HST $15.40
- Revenue Growth
- MRNA N/A
- HST 7.54
- 52 Week Low
- MRNA $23.15
- HST $12.22
- 52 Week High
- MRNA $170.47
- HST $19.36
- Technical
- Relative Strength Index (RSI)
- MRNA 38.02
- HST 57.61
- Support Level
- MRNA $23.70
- HST $14.37
- Resistance Level
- MRNA $28.52
- HST $15.00
- Average True Range (ATR)
- MRNA 1.36
- HST 0.37
- MACD
- MRNA -0.09
- HST 0.15
- Stochastic Oscillator
- MRNA 11.11
- HST 83.92
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.